Small cell lung cancer extensive stage

Small Cell Lung Cancer Extensive Stage

Extensive stage small cell lung cancer is an aggressive form of lung cancer that has spread beyond a single area of the chest. While there is no cure for this stage, modern treatments including chemotherapy and immunotherapy can help patients live longer and improve their quality of life.

Table of contents

What Is Extensive Stage Small Cell Lung Cancer?

Small cell lung cancer (SCLC) is generally divided into two stages: limited stage and extensive stage. Extensive stage small cell lung cancer means that the cancer has spread beyond a single area that can be treated with radiotherapy (treatment using high-energy rays to destroy cancer cells) to just one part of the body[1].

Doctors consider SCLC to be extensive stage when the cancer has spread in one or more of the following ways[1][6]:

  • Widely throughout one lung
  • To both lungs
  • To lymph nodes on the opposite side of the chest
  • To fluid surrounding the lungs, causing a build-up called malignant pleural effusion (fluid containing cancer cells in the space around the lungs)
  • Between the heart and the sack that surrounds the heart, causing a build-up called malignant pericardial effusion
  • To other parts of your body such as the brain, liver, bones, or adrenal glands

About two-thirds of people diagnosed with small cell lung cancer have extensive stage disease at the time of their diagnosis[6][9]. This happens because SCLC often does not cause symptoms in its early stages, so it is frequently not detected until it has already spread[6].

How the Cancer Spreads in Your Body

Small cell lung cancer is a fast-growing cancer that starts when healthy cells in your lungs change into cancerous cells. These cells then divide and multiply uncontrollably, eventually clumping together to form masses called tumors in your lungs[2].

These tumors may shed cancer cells that your blood or lymph (fluid that travels through your body to your lymph nodes) pick up and carry throughout your body. Once the cells have spread, they may create new cancerous tumors in other organs[2].

Small cell lung cancer typically spreads to[2]:

  • Lymph nodes
  • Bones
  • Brain
  • Liver
  • Adrenal glands (glands located near your kidneys)
  • Lungs
  • Lymph nodes
  • Brain
  • Liver
  • Bones
  • Adrenal glands

Symptoms of Extensive Stage SCLC

People with extensive stage small cell lung cancer may experience a range of symptoms. These symptoms can be similar to other less serious conditions, so having them does not necessarily mean you have lung cancer[2][6]:

  • Chest pain or discomfort
  • Chronic cough that doesn’t go away or gets worse
  • Coughing up blood (also called hemoptysis)
  • Difficulty breathing or shortness of breath
  • Wheezing
  • Hoarseness
  • Facial swelling
  • Swollen neck veins
  • Fatigue (feeling extremely tired)
  • Loss of appetite
  • Unexplained weight loss
  • Difficulty swallowing

If you smoke or used to smoke and notice these types of symptoms, it is important to talk to a healthcare provider. They will evaluate your situation and recommend any next steps[2].

Treatment Options

There is no cure for extensive stage small cell lung cancer. However, treatment can shrink the size of tumors, help you live longer, and improve your quality of life[6][9].

Chemotherapy

The main treatment for extensive stage SCLC is chemotherapy (medication that kills cancer cells or stops them from growing). Because the cancer has spread throughout the body, chemotherapy is often the first choice as it can reach cancer cells wherever they are[1][6].

Chemotherapy for extensive stage SCLC typically uses two drugs in combination. The most common combinations include a platinum-based drug like cisplatin or carboplatin together with etoposide[12].

Chemotherapy can shrink tumors around the body, reduce symptoms, and help patients live longer. However, it can cause side effects that vary from person to person[6].

Immunotherapy

In recent years, immunotherapy (treatment that helps your immune system fight cancer) has become an important part of treating extensive stage SCLC. Immunotherapy drugs work with your immune system to attack cancer cells[4].

Doctors may use immunotherapy drugs like atezolizumab, durvalumab, or pembrolizumab in combination with chemotherapy as a first treatment for extensive stage SCLC. These drugs can be given at the same time as chemotherapy or used after chemotherapy stops working[3][6].

The addition of immunotherapy to chemotherapy has helped patients with extensive stage SCLC live longer than with chemotherapy alone[9].

Radiation Therapy

In extensive stage SCLC, radiation therapy is usually only used if you have a good response to chemotherapy. Radiation can be used to target specific areas of the body where cancer has spread, such as the brain or bones. This can help shrink tumors and improve symptoms[6][8].

Your doctor might also suggest radiation therapy to the brain to reduce the risk of cancer spreading there. This is called prophylactic cranial irradiation. Instead of radiation to the brain, your doctor might suggest regular monitoring through routine MRI scans[1].

New Treatment Options

Promising new treatments are offering hope to patients with extensive stage SCLC. One example is tarlatamab, a type of drug called a bispecific T-cell engager, which was approved by the FDA to treat extensive stage small cell lung cancer that gets worse during or after chemotherapy. This drug works by engaging the body’s disease-fighting T-cells to attack cancer cells[14].

What to Expect: Outlook and Survival

People can survive for varying amounts of time with extensive stage SCLC. In most cases, treatment can shrink the size of tumors and prolong someone’s life[6].

Although most cases of extensive stage SCLC are initially sensitive to chemotherapy, the cancer frequently comes back after treatment. When it returns, it may be in a more aggressive form and resistant to treatments that previously helped[9].

Through treatment, doctors aim to improve quality of life as much as possible in people with extensive stage SCLC. It is important to discuss all available options with your healthcare team and what to expect from them when making decisions about your care[6].

For decades, treatment options for extensive stage SCLC remained largely unchanged. However, significant advances occurred starting in 2018 with the approval of new immunotherapy drugs, offering more options and hope to patients[3].

Understanding Staging Systems

Doctors use staging systems to describe how advanced the cancer is and to help decide on the best treatment. For small cell lung cancer, two different systems are commonly used[1][7].

Limited and Extensive Stage System

The traditional system divides SCLC into two stages: limited stage and extensive stage. This simpler system has been used for many years to guide treatment decisions[1][7].

TNM Staging System

The American Joint Committee on Cancer now recommends using the TNM staging system for small cell lung cancer. TNM stands for Tumor (T), Node (N), and Metastasis (M)[1]:

  • T describes the size of the tumor
  • N describes whether there are cancer cells in nearby lymph nodes
  • M describes whether the cancer has spread to parts of the body further away from where it started

In the TNM system, extensive stage disease generally corresponds to stage 4 small cell lung cancer. This means the cancer has spread to distant parts of the body[1].

Many doctors now use both staging systems together because the TNM system provides more detailed information that can help with treatment decisions[7].

Ongoing Clinical Trials on Small cell lung cancer extensive stage

  • Study of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer

    Recruiting

    1 1 1 1
    France Germany Italy The Netherlands Poland Romania +1
  • Testing Tarlatamab in Patients with Advanced Small-Cell Lung Cancer Who Have Poor Physical Condition

    Recruiting

    1 1
    Investigated drugs:
    Germany
  • Study of tarlatamab with durvalumab, carboplatin and etoposide versus standard treatment in patients with previously untreated extensive stage small cell lung cancer

    Recruiting

    1 1 1 1
    Austria Belgium Denmark France Germany Greece +7
  • Study Comparing Sacituzumab Govitecan and Standard Treatment for Patients with Previously Treated Extensive Stage Small Cell Lung Cancer

    Recruiting

    1 1 1 1
    Belgium France Germany Greece Hungary Italy +5
  • Study Comparing BMS-986489 with Chemotherapy to Atezolizumab with Chemotherapy for First-Line Treatment in Patients with Extensive-Stage Small Cell Lung Cancer

    Recruiting

    1 1 1 1
    Austria Belgium Czechia France Germany Greece +5
  • Study of Ifinatamab Deruxtecan with Atezolizumab and Carboplatin for Patients with Extensive-Stage Small Cell Lung Cancer

    Recruiting

    1 1 1
    France Spain
  • Study on Maintenance Therapy with Durvalumab and Olaparib for Patients with Extensive Disease Small-Cell Lung Cancer

    Recruiting

    1 1 1
    Investigated drugs:
    Germany
  • Study on Niraparib with Immunotherapy for Patients with SLFN11-Positive Extensive-Stage Small Cell Lung Cancer

    Recruiting

    1 1 1
    France Germany Italy Romania Spain
  • Study for Patients with Lung or Urinary Tract Cancer Continuing Treatment with Durvalumab, Infliximab, and Mycophenolate Mofetil

    Recruiting

    1 1 1 1
    Belgium Bulgaria Czechia France Germany Greece +5
  • Study on Pembrolizumab and Olaparib for Patients with Extensive-Stage Small-Cell Lung Cancer

    Recruiting

    1 1 1
    Italy

References

https://www.cancerresearchuk.org/about-cancer/lung-cancer/stages-types/limited-extensive

https://my.clevelandclinic.org/health/diseases/6202-small-cell-lung-cancer

https://pmc.ncbi.nlm.nih.gov/articles/PMC9330463/

https://www.imfinzi.com/small-cell-lung-cancer/about-sclc.html

https://www.lungevity.org/lung-cancer-basics/types-of-lung-cancer/small-cell-lung-cancer-sclc

https://www.medicalnewstoday.com/articles/extensive-stage-small-cell-lung-cancer

https://pmc.ncbi.nlm.nih.gov/articles/PMC3266593/

https://www.cancer.org/cancer/types/lung-cancer/treating-small-cell/by-stage.html

https://pmc.ncbi.nlm.nih.gov/articles/PMC10404428/

https://www.cancer.gov/types/lung/patient/small-cell-lung-treatment-pdq

https://lcfamerica.org/story/treating-limited-stage-and-extensive-stage-sclc/

https://emedicine.medscape.com/article/280104-treatment

https://www.cancerresearchuk.org/about-cancer/lung-cancer/stages-types/limited-extensive

https://www.uchicagomedicine.org/cancer/types-treatments/lung-cancer/small-cell-lung-cancer

https://my.clevelandclinic.org/health/diseases/6202-small-cell-lung-cancer

https://www.cancer.org/cancer/types/lung-cancer/treating-small-cell/by-stage.html

https://www.cancerresearchuk.org/about-cancer/lung-cancer/stages-types/limited-extensive

https://sclc.lungevity.org/sclc/about-small-cell-lung-cancer

https://www.healthline.com/health/small-cell-lung-cancer/what-it-means-when-your-small-cell-lung-cancer-becomes-extensive-stage

https://www.lungcancergroup.com/lung-cancer/small-cell-lung-cancer/

https://www.medicalnewstoday.com/articles/extensive-stage-small-cell-lung-cancer